National Health Act (Pharmaceutical Benefits Early Supply) Amendment September 2013 specification under subsection 84AAA(2) (No. PB 60 of 2013) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 60 of 2013
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2013 - specification under subsection 84AAA(2)1
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Gregory O’Toole, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 14 August 2013
GREGORY O’TOOLE
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2013 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as No. PB 60 of 2013.
2 Commencement
This Instrument commences on 1 September 2013.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, after item dealing with Anastrozole
insert in the columns in the order indicated:
| Apixaban | Tablet 2.5mg | Oral | 60 | 5 |
| Tablet 5mg | Oral | 60 | 5 |
Schedule 1, after item dealing with Clopidogrel with aspirin
insert in the columns in the order indicated:
| Dabigatran | Capsule 110 mg (as mesilate) | Oral | 60 | 5 |
| Capsule 150 mg (as mesilate) | Oral | 60 | 5 |
Schedule 1, item dealing with Flutamide
insert in the columns in the order indicated:
| Tablet 250mg, 30 | Oral | 3 | 5 |
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0